Ligase Enzymes Market worth $0.36 billion by 2030
The report "Ligase Enzymes Market by Type (DNA, RNA), Source (Viral, Bacterial, Eukaryotic), Grade (RUO, GMP, Diagnostic), Molecular Biology Workflow (Cloning, Sequencing, Synthetic Biology), Application (Research, Diagnostic, Therapeutic) - Global Forecast 2030", is expected to reach USD 0.36 billion by 2030 from 0.26 billion in 2025, at a CAGR of 6.8% during the forecast period.
Browse 419 market data Tables and 52 Figures spread through 310 Pages and in-depth TOC on "Ligase Enzymes Market by Type (DNA, RNA), Source (Viral, Bacterial, Eukaryotic), Grade (RUO, GMP, Diagnostic), Molecular Biology Workflow (Cloning, Sequencing, Synthetic Biology), Application (Research, Diagnostic, Therapeutic) - Global Forecast 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/ligase-enzymes-market-257141225.html
The ligase enzymes market is experiencing steady growth, supported by rising demand for advanced molecular biology tools across research, diagnostics, and biotechnology applications. The growing use of ligase enzymes in next-generation sequencing, synthetic biology, and genetic engineering is creating new opportunities, particularly as precision medicine and personalized therapies are increasingly adopted. Growing investments in R&D by pharmaceutical and biotechnology companies and government funding for genomics and life sciences research are further driving adoption. In addition, the increasing application of ligase enzymes in clinical diagnostics, such as cancer and infectious disease testing, is broadening their market potential.
By type, the RNA ligases segment is expected to grow at the highest CAGR during the forecast period.
Based on type, the ligase enzymes market is segmented into DNA, RNA, and other ligases. The RNA ligases segment is estimated to register the highest CAGR in the market. The high share of this segment is attributed to its expanding applications in next-generation sequencing (NGS), RNA interference studies, and transcriptomics research. The increasing focus on RNA-based therapeutics, including mRNA vaccines and RNA interference therapies, creates a higher demand for efficient RNA ligation tools. Additionally, the rising use of RNA ligases in library preparation workflows for single-cell sequencing and small RNA analysis further drives adoption. Growing investments in RNA biology and the surge in infectious disease research, particularly in developing RNA-targeted drugs and vaccines, are expected to strengthen the market potential for RNA ligases in the coming years.
By molecular biology workflow, the cloning workflow segment accounted for the largest share of the market in 2024.
By molecular biology workflow, the ligase enzymes market is divided into cloning, synthetic biology, sequencing, and nucleic acid amplification workflows. In 2024, the cloning workflow segment accounted for the largest share of the market. Cloning applications continue to dominate due to their essential role in academic research, functional genomics, and biopharmaceutical development. The growth of gene therapy and the expansion of recombinant protein production pipelines further reinforce the demand for ligase enzymes in cloning. Moreover, technological advancements such as high-throughput cloning platforms and automation enhance the reproducibility and scalability of ligase-dependent cloning techniques, further driving adoption.
North America accounted for the largest share of the market in 2024.
By region, the market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America accounted for the largest share of the global ligase enzymes market, driven by its well-established biotechnology and pharmaceutical industries, strong presence of leading sequencing and molecular diagnostics companies, and significant investments in genomics research. The region benefits from strong funding support from agencies such as the NIH, a high concentration of academic & research institutions, and advanced healthcare infrastructure. Moreover, early adoption of next-generation sequencing (NGS), synthetic biology, and precision medicine applications has provided consistent demand for ligase enzymes across research and clinical settings.
Key players in the ligase enzymes market include New England Biolabs (UK), Promega Corporation (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), and Danaher (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Ligase Enzymes Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
